• Markets
    • icon
  • Companies
ADR · ASX

Adherium Ltd. (ASX:ADR)

AU$0.003

 0.0 (0.0%)
ASX:Live
04/12/2023 12:00:00 AM
HALO Ords GROWTH AUS Consensus Expensive All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

ADR Overview

ADR Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About ADR

Website

Adherium Ltd.

Telephone

N/A

Address

Level 14 333 Collins Street Melbourne, Victoria (VIC) 3000

Description

Adherium Ltd. engages in the development, manufacture, and supply of digital health technologies. It operates through the following geographical segments: New Zealand and Australia, South-East Asian Countries, and Other Countries. The firm's Hailie system is transforming management of chronic respiratory conditions, especially asthma and chronic obstructive pulmonary disease. The company was founded by Garth Sutherland in 2001 and is headquartered in Melbourne, Australia.

ADR Price Chart

Key Stats

Market Cap

AU$15.00M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

US$1,416.00

1 week

0%

1 month

0%

YTD

-25%

1 year

-40%

All time high

0.72

Key Fundamentals

EPS 3 yr Growth

-93.400%

EBITDA Margin

-366.90%

Operating Cashflow

-$9m

Free Cash Flow Return

-125.40%

ROIC

-133.30%

Interest Coverage

-1,953.50

Quick Ratio

3.30

Other Data

Shares on Issue (Fully Dilluted)

4999m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

NZD

Short Sell (% of issue)

0.00

ADR Announcements

Latest Announcements

Date Announcements

31 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 October 22

Becoming a substantial holder

×

Becoming a substantial holder

31 October 18

Adherium Investor Conference Call Presentation

×

Adherium Investor Conference Call Presentation

31 August 22

Preliminary Final Report

×

Preliminary Final Report

30 September 22

Appendix 4G

×

Appendix 4G

30 September 22

Corporate Governance Statement 2022

×

Corporate Governance Statement 2022

30 September 22

Annual Report to shareholders

×

Annual Report to shareholders

30 September 22

Change in substantial holding

×

Change in substantial holding

30 September 19

Annual Report to shareholders 30 June 2019

×

Annual Report to shareholders 30 June 2019

30 September 15

New Clinical Data Presented at ERS 2015

×

New Clinical Data Presented at ERS 2015

30 October 20

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

30 October 17

Investor Conference Call Presentation - with notes

×

Investor Conference Call Presentation - with notes

30 November 23

CEO Presentation to the Annual General Meeting

×

CEO Presentation to the Annual General Meeting

30 November 23

Results of Meeting & Approval of Share Consolidation

×

Results of Meeting & Approval of Share Consolidation

30 November 22

CEO's Address to Shareholders at AGM

×

CEO's Address to Shareholders at AGM

30 November 22

Results of Meeting and Director Update

×

Results of Meeting and Director Update

30 November 20

Adherium CEO Presentation to AGM

×

Adherium CEO Presentation to AGM

30 May 22

Adherium Senior Management Update

×

Adherium Senior Management Update

30 January 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 August 23

Change of Company Address

×

Change of Company Address

30 August 23

Annual Report to shareholders

×

Annual Report to shareholders

30 August 23

Appendix 4G & Corporate Governance Statement

×

Appendix 4G & Corporate Governance Statement

30 April 21

EGM presentation

×

EGM presentation

29 September 17

Annual Report to shareholders

×

Annual Report to shareholders

29 November 17

Presentation to AGM

×

Presentation to AGM

29 August 22

Application for quotation of securities - ADR

×

Application for quotation of securities - ADR

29 August 17

Investor Conference Call Presentation

×

Investor Conference Call Presentation

29 August 17

Investor Conference Call Presentation - with notes

×

Investor Conference Call Presentation - with notes

ADR Fundamentals

Per Share Records

Historical data

Forecasted data

NZD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.00 -0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 53.7 72.5 47.8 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.00 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 61.9 28.1 51.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -73.8 -65.0 -91.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.00 0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 17.6 -62.0 -26.5 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 901 2,174 4,083 Lock Lock Lock
Basic m Lock Lock Lock Lock 901 2,174 4,083 Lock Lock Lock

Financial Records

Historical data

Forecasted data

NZD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 1 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -81.9 31.9 504.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 12 12 14 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -1 -1 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -216.5 12.5 345.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -196.8 -130.4 53.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 297 230 47 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -12 -13 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -42.3 -3.6 7.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,047.6 -2,392.2 -366.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -12 -13 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -38.6 -3.8 7.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,083.8 -2,427.4 -372.8 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -15 -13 -12 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 -3 -2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -15 -10 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock -31.9 33.2 1.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,749.6 -1,898.7 -308.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -11 -10 -9 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 22 0 13 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -11 -10 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -51.6 12.5 5.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -28.2 -18.7 -2.9 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 15 5 9 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 17 9 13 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -15 -5 -9 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 3 3 3 Lock Lock Lock
Equity $m Lock Lock Lock Lock 14 6 9 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 14 6 9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 314.7 -60.2 65.1 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -88.2 -117.7 -77.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -107.1 -181.4 -107.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -142.0 -130.7 -160.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -172.6 -102.4 -133.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -129.4 -98.0 -125.4 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

NZD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -5.5 -12,655.0 -1,953.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.2 0.4 0.8 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -108.1 -93.9 -98.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.6 2.8 3.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.3 2.4 3.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 89.8 64.3 72.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -375.3 -325.4 -267.6 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.7 0.5 1.8 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.1 1.2 1.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.1 0.4 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 174.8 63.3 30.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.3 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.3 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -3,841.9 -2,429.3 -366.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -90.4 -150.6 -92.2 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -88.2 -117.7 -77.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.5 1.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -107.1 -181.4 -107.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -107.1 -181.4 -107.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 319.3 304.4 280.5 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 523.8 738.3 203.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 843.1 1,042.6 483.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 301.3 142.4 141.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 541.8 900.3 342.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ADR Shortsell

Frequently Asked Questions

The current share price of Adherium Ltd. (ADR:ASX) is AU$0.003.
The 52-week high share price for Adherium Ltd. (ADR:ASX) is AU$0.00.
The 52-week low share price for Adherium Ltd. (ADR:ASX)? is AU$0.00.
Adherium Ltd. (ADR:ASX) does not pay a dividend.
Adherium Ltd. (ADR:ASX) does not pay a dividend.
Adherium Ltd. (ADR:ASX) has a franking level of 0%.
Adherium Ltd. (ADR:ASX) is classified in the Healthcare.
The current P/E ratio for Adherium Ltd. (ADR:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.